Uterine Wall Membrane Anchor Device for the Prevention of Preterm Premature Rupture of the Membranes Following Fetoscopic Surgery
Award amount
$224,642Program and phase
SBIR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- FANNIN PARTNERS LLC
- Proposal award date
- 2017-09-21
- Contract end date
- 2019-08-31
- UEI
- DAHAYJEBV8K1
- Solicitation number
- PA16-302
- Topic code
- NICHD
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Developing Scg3 Raptamers as a novel targeted therapy for wet AMD
- Investigation of a Novel PDE4B Inhibitor for Stimulant Use Disorder
- Bedside right-heart catheterization for early diagnosis and more effective management of patients with heart failure and primary pulmonary hypertension
- Expediting the Biomarker Discovery Process Through a Novel Bead-Based Aptamer Capture Platform
- Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Developing RNA therapeutics for rare neurodevelopmental disorders
- SPIRIT Club CBI Pathway: A novel streaming platform for physical activity and wellness promotion for chronic brain injury survivors
- Zip-stitch for Laparoscopic Hysterectomy - Clinical Validation
- Point-of-care Testing (POCT) Tool Development for Critical Oxytocin Measurement
- Novel, Non-hormonal Therapeutic for Endometriosis
Research funding history
15 SBIR/STTR records share this UEI (2017–2025). Reported award amounts total $10,167,978. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services